Indeed, JA pre-treatment reduces the creation of H 2 O 2 and other free radicals which openly affect the lipid membranes
We offer and utilize glutathione IV pushes and other IV nutrition solutions at my AMA Regenerative offices in Orange County and Beverly Hills, CA, and am thrilled to offer more glutathione resources to my patients!"Alice Pien, MD, Medical Director AMA Regenerative Medicine "Being a sportsman and a health-conscious individual, I am always on the lookout for something to better my health
CagriSema: Cagrilintide + Semaglutide dosing Simultaneous start (from day 1): Semaglutide titration: Weeks 1-4: 0.25mg weekly Weeks 5-8: 0.5mg weekly Weeks 9-12: 1.0mg weekly Weeks 13-16: 1.7mg weekly Week 17+: 2.4mg weekly Cagrilintide titration (running parallel): Weeks 1-4: 0.6mg weekly Weeks 5-8: 1.2mg weekly Weeks 9-12: 1.8mg weekly Week 13+: 2.4mg weekly CagriSema vs monotherapy comparison: Key points: Both injected same day (different sites) OR different days Cagrilintide reaches target faster (13 weeks vs 17 weeks) Side effects additive but manageable Maximum synergy Sequential start (adding cagrilintide later): Already on semaglutide 2.4mg: Stable on semaglutide for 4+ weeks Continue semaglutide 2.4mg weekly Add cagrilintide starting 0.6mg weekly Titrate cagrilintide: 0.6mg (weeks 1-4) 1.2mg (weeks 5-8) 1.8mg (weeks 9-12) 2.4mg (week 13+) Maintain both at 2.4mg Advantages of sequential: Semaglutide establishes baseline weight loss first Easier to attribute new side effects (know it's cagrilintide) Less overwhelming than both at once Can see incremental benefit of adding cagrilintide Expected combination results: 15-20% average weight loss (most users) 20-25% weight loss (excellent responders) Superior to either alone consistently Optimize your CagriSema protocol at SeekPeptides - we help you coordinate both titration schedules and manage combined side effects
Join our AI workshop to create videos like this
I use them to supplement what Im already doing, to make sure I get to my goals just a little bit faster. The post is sponsored by a company which sells BPC-157 and semaglutide (Ozempic) without a prescription, as well as other compounds like GHK-CU and retatrutide
